Novan Reports First Quarter 2023 Financial Results and Provides Corporate Update May 15, 2023 06:45AM
Novan (NOVN) Reports FY22 Revenue of $23.7M, Provides Corporate Update Mar 30, 2023 06:32AM
Novan Reports Full Year 2022 Financial Results and Provides Corporate Update Mar 30, 2023 06:30AM
Novan Reports Full Year 2022 Financial Results and Provides Corporate Update Mar 30, 2023 06:30AM
Novan (NOVN) Submits NDA to the U.S. FDA for Berdazimer Gel, 10.3% (SB206) for the Treatment of Molluscum Contagiosum Jan 6, 2023 08:01AM


Jan 6, 2023 08:00AM Novan Submits New Drug Application to the U.S. FDA for Berdazimer Gel, 10.3% (SB206) for the Treatment of Molluscum Contagiosum
Jan 6, 2023 08:00AM Novan Submits New Drug Application to the U.S. FDA for Berdazimer Gel, 10.3% (SB206) for the Treatment of Molluscum Contagiosum
Nov 14, 2022 07:00AM Novan Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Nov 14, 2022 07:00AM Novan Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Jul 29, 2019 06:00PM Mylan deal puts future of its beleaguered EpiPen in spotlight
Dec 19, 2018 07:28PM Exclusive: Big Pharma returning to U.S. price hikes in January after pause
Aug 8, 2018 08:25AM Novan Provides Business Update via 10-Q, Adopts Incentive Plan and Agrees to CEO Contract
Jul 18, 2018 04:20AM Novartis hints at 2018 outlook hike despite drug price freeze
Sep 15, 2017 07:06AM Drug industry on tenterhooks as Maryland price-gouging law nears
May 4, 2017 09:18AM How drugmakers face global push-back on high prices
Apr 25, 2016 07:18AM Valeant names Papa CEO after he resigns from Perrigo